LUXTURNA
voretigene neparvovec-rzyl · KIT · Spark Therapeutics, Inc.
Luxturna is a gene therapy injection used to treat a rare inherited eye disease called RPE65 mutation-associated retinal dystrophy, which causes progressive vision loss. It works by delivering a healthy copy of the RPE65 gene directly into the eye to help restore vision.
Key Facts
- Brand Name
- LUXTURNA
- Generic Name
- voretigene neparvovec-rzyl
- NDC Code (Product)
71394-415- Manufacturer
- Spark Therapeutics, Inc.
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA125610
- Marketing Start
- 12/19/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is LUXTURNA used for?
Luxturna is a gene therapy injection used to treat a rare inherited eye disease called RPE65 mutation-associated retinal dystrophy, which causes progressive vision loss. It works by delivering a healthy copy of the RPE65 gene directly into the eye to help restore vision.
Is LUXTURNA a controlled substance?
LUXTURNA is not classified as a controlled substance by the DEA.
What is the generic name for LUXTURNA?
The generic name for LUXTURNA is voretigene neparvovec-rzyl. There are no other listed brand versions of voretigene neparvovec-rzyl.
What is the NDC code for LUXTURNA ?
The NDC (National Drug Code) for LUXTURNA is 71394-415, listed by Spark Therapeutics, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)